Cycle Computing CEO Jason Stowe sees a cloudy future for the life sciences based on the level of adoption for genome sequencing, bioinformatics, molecular modeling and drug discovery among a host of other industry-specific applications. These applications create a tremendous amount of data, which means life sciences companies are forced to spend many thousands on their own clusters. Cloud computing offers a workaround to the capital expense involved but working with the cloud can be a challenge at first. Cloud HPC clusters can be started without extensive programming (which is required on EC2) which means that life sciences researchers can turn on and off at will without dramatic time investment–an important consideration when time-to-market is a significant concern.
Specialized HPC Clusters in the Cloud
June 28, 2010